top of page

ACHIEVE YOUR NEXT BREAKTHROUGH

using the world’s most powerful 3D in situ
multi-omic analysis technology

WHY STELLAROMICS

Empowering a brighter biomedical future

Welcome to the new world of in situ analysis. Now you can capture high resolution 3D multi-omic information from thick tissue samples, mapping gene expression patterns while preserving the spatial integrity and anatomical structure of the cells in the tissue being studied.

home.png

STELLAR TECHNOLOGY

Faster, richer discovery straight from the STARs

Stellaromics uses industry-leading STARmap (Spatially-resolved Transcript Amplicon Readout mapping) technology to optically extract multi-omic information from biologic tissue so researchers can better understand tissue functions and dysfunctions, in which cells may be targeted by specific interventions.

STMP.png
iStock-1323369694.jpg

INTRODUCING PLEXA

TM

Powerful, fully annotated multi-omic maps at your fingertips

Discover how individual cells work and how multiple cell types relate to each other across imaging layers using the Stellaromics Plexa suite of devices, reagents, software, and services. Plexa starter kit available now to be tested in your favorite tissues. Also inquiry and preorder the Plexa In Situ Analyzer for early access.

iStock-1309776504b.jpg

ABOUT STELLAROMICS

Power. Precision. Innovation. Ingenuity.

Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Plexa suite of products was developed to extend their progress by empowering others to innovate alongside them.

icon.png

Stellaromics In Numbers

1 cent

Cell transcriptome profiling within 1 cent/cell

4000 genes

Imaging up to 4000 genes at once

40 nt

Targeting RNA species as short as 40 nucleotides

1 million

Studying 1 million cells per experiment

200 um

Analyzing biologic tissue up to 200 um thickness

200 nm 

Achieving spatial resolution of 200 nm 

bottom of page